Share To

Article Url


Manuscript ID : JVM-2005-1136 (R5) Visit : 243 Page: 59 - 71

10.30495/jvm.2021.675115

20.1001.1.22518851.1399.16.2.5.1

Article Type: Original Research

Subject Areas :

آرش کلانتری 1 , صمد فراشی بناب 2 , هادی کیوانفر 3

1 - گروه میکروبیولوژی، دانشگاه آزاد اسلامی، واحد علوم و تحقیقات، تهران، ایران
2 - گروه ایمونولوژی، دانشکده پزشکی، دانشگاه علوم پزشکی تهران، تهران، ایران
3 - گروه میکروبیولوژی، دانشکده دامپزشکی، دانشگاه تهران، تهران، ایران

Received: 2020-05-26 Accepted : 2020-08-25 Published : 2021-03-18

Keywords:

Abstract :

References:


  1. Aldous, E.W. & Alexander DJ. (2001). Detection and differentiation of newcastle disease virus (avian paramixovirus Type 1). Avian Pathol. 30:117-128.
    2.
  2. Alexander, D.J. (2003). Newcastle disease and other avian Paramyxoviruses infections. In: Saif YM, et al. (Eds.), Iowa State University Press, Ames, USA, p. 63-99.
    3.
  3. Al-Shammari, A. M., Rameez, H. & Al-Taee, M. F. (2016). Newcastle disease virus, rituximab, and doxorubicin combination as anti-hematological malignancy therapy. Oncolytic virotherapy, 5:
    4.
  4. Bai, F. L., Yu, Y. H., Tian, H., Ren, G. P., Wang, H., Zhou, B., ... & Li, D. S. (2014). Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy. Cancer biology & therapy, 15:1226-1238.
    5.
  5. Bolchon, S. & Demeret, C. (2003). The regulatory E2 proteins of human genital papillomaviruses are pro-apoptotic. Biochimie, 85: 813-819.
    6.
  6. Bonab, S. & Khansari, N. (2017). Virotherapy with Newcastle disease virus for cancer treatment and its efficacy in clinical trials. MOJ Immunology, 5:
    7.
  7. Brown, J.J., Short, S.P., Stencel-Baerenwald, J., Urbanek, K., Pruijssers, A.J., McAllister, N., Ikizler, M., Taylor, G., Aravamudhan, P., Khomandiak, S. & Jabri, B. (2018). Reovirus-induced apoptosis in the intestine limits establishment of enteric infection. Journal of virology, 92:e02062-17.
    8.
  8. Cuadrado-Castano, S., Sanchez-Aparicio, M.T., García-Sastre, A. & Villar, E. (2015). The therapeutic effect of death: Newcastle disease virus and its antitumor potential. Virus research, 209:56-66.
    9.
  9. Cheng, X., Wang, W., Xu, Q., Harper, J., Carroll, D., Galinski, M. S., ... & Jin, H. (2016). Genetic modification of oncolytic Newcastle disease virus for cancer therapy. Journal of virology, 90:5343-5352.
    10.
  10. Chia, S. L., Yusoff, K. & Shafee, N. (2014). Viral persistence in colorectal cancer cells infected by Newcastle disease virus. Virology journal, 11:
    11.
  11. Coffey, M. C., Strong, J. E., Forsyth, P. A. & Lee, P. W. (1998). Reovirus therapy of tumors with activated Ras pathway. Science, 282:1332-1334. ‏‏
    12.
  12. Cuadrado-Castano, S., Ayllon, J., Mansour, M., De La Iglesia-Vicente, J., Jordan, S., Tripathi, S., ... & Villar, E. (2015). Enhancement of the proapoptotic properties of newcastle disease virus promotes tumor remission in syngeneic murine cancer models. Molecular­­ cancer therapeutics ,14:1247-1258.
    13.
  13. Elankumaran, S., Rockemann, D. & Samal, S. K. (2006). Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death. Journal of virology, 80:7522-7534.
    14.
  14. Elmore, S. (2007). Apoptosis: a review of programmed cell death. Toxicologic pathology, 35:495-516.
    15.
  15. Fábián, Z., Csatary, C. M., Szeberényi, J. & Csatary, L. K. (2007). p53-independent endoplasmic reticulum stress-mediated cytotoxicity of a Newcastle disease virus strain in tumor cell lines. Journal of virology , 81:2817-2830.
    16.
  16. Farashi-Bonab, S. & Khansari, N. (2017). Immunobiology of anticancer virotherapy with Newcastle disease virus in cancer patients. Vaccin Res Open J, 1:45-53.
    17.
  17. Fuller, C.M., Collins, M.S., Easton, A.J., & Alexander DJ. (2007). Partial characterisation of five cloned viruses differing in pathogennicity, obtained from a single isolate of pigeon paramyxovirus type 1 (PPMV-1) following passage in fowls’ eggs. Arch Virol. 152:1575-1582.
    18.
  18. Gohm, D.S., Thür, B. & Hofmann, M.A.(2000). Detection of Newcastle disease virus in organs and faeces of experimentally infected chickens using RT-PCR. Avian Pathology, 29:2, 143-152.
    19.
  19. Han, X., Tian, Y., Guan, R., Gao, W., Yang, X., Zhou, L. & Wang, H. (2017). Infectious bronchitis virus infection induces apoptosis during replication in chicken macrophage HD11 cells. Viruses, 9:198.
    20.
  20. Huynh, A.K.D., Walch-Rückheim, B., Smola, S. & Graf, N. (2020). Combined infection with oncolytic viruses (OVs) induces synergistic and additive cell death in glioblastoma multiforme (GBM) cell lines. Klinische Pädiatrie, 232.
    21.
  21. 2019. Virus Taxonomy: 2019 Release. talk.ictvonline.org.
    22.
  22. Jin, Z. & El-Deiry, W.S., 2005. Overview of cell death signaling pathways. Cancer biology & therapy, 4:147-171.
    23.
  23. Kerr, JF. Wyllie,AH. Currie, AR. (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:239-257.
    24.
  24. Koks, C. A., Garg, A. D., Ehrhardt, M., Riva, M., Vandenberk, L., Boon, L., ... & Van Gool, S. W. (2015). Newcastle disease virotherapy induces long‐term survival and tumor‐specific immune memory in orthotopic glioma through the induction of immunogenic cell death. International journal of cancer, 136:E313-E325.
    25.
  25. Lai, I.H., Chang, C.D. & Shih, W.L. (2019). Apoptosis Induction by Pseudorabies Virus via Oxidative Stress and Subsequent DNA Damage Signaling. Intervirology, 62:105-112.
    26.
  26. Lauber, K., Blumenthal, S.G., Waibel, M. & Wesselborg, S. (2004). Clearance of apoptotic cells: getting rid of the corpses. Mol Cell, 14:277–87.
    27.
  27. Lazar, I., Yaacov, B., Shiloach, T., Eliahoo, E., Kadouri, L., Lotem, M., ... & Ben-Yehuda, D. (2010). The oncolytic activity of Newcastle disease virus NDV-HUJ on chemoresistant primary melanoma cells is dependent on the proapoptotic activity of the inhibitor of apoptosis protein Livin. Journal of virology, 84:639-646. ‏
    28.
  28. Mansour, M., Palese, P. & Zamarin, D. (2011). Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells. Journal of virology, 85:6015-6023.
    29.
  29. Marcato, P., Shmulevitz, M., Pan, D., Stoltz, D. & Lee, P. W. (2007). Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependentrelease. Molecular therapy, 15:1522-1530. ‏
    30.
  30. Nagata, S. (2018). Apoptosis and clearance of apoptotic cells. Annual review of immunology, 36, 489-517.
    31.
  31. Nanthakumar, T., Katari, R.S., Tieari, A.K., Butchaiah, G. & Kataria, J.M. (2000). Pathotyping of newcastle disease viruses by RT-PCR and restriction enzyme analysis. Res. Commun., 24:275-286.
    32.
  32. Nainu, F., Shiratsuchi, A. & Nakanishi, Y. (2017). Induction of apoptosis and subsequent phagocytosis of virus-infected cells as an antiviral mechanism. Frontiers in immunology, 8, p.1220.
    33.
  33. Niavarani, S.R., Lawson, C., Boudaud, M., Simard, C. & Tai, L.H. (2020). Oncolytic vesicular stomatitis virus–based cellular vaccine improves triple-negative breast cancer outcome by enhancing natural killer and CD8+ T-cell functionality. Journal for immunotherapy of cancer, 8.
    34.
  34. Niemann, J. & Kühnel, F. (2017). Oncolytic viruses: adenoviruses. Virus Genes, 53:700-706.
    35.
  35. Nichols, J.E., Niles, J.A., Fleming, E.H. & Roberts, N.J. (2019). The role of cell surface expression of influenza virus neuraminidase in induction of human lymphocyte apoptosis. Virology, 534, 80-86.
    36.
  36. Park, S. H., Breitbach, C. J., Lee, J., Park, J. O., Lim, H. Y., Kang, W. K., ... & Patt, R. (2015). Phase 1b trial of biweekly intravenous Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus in colorectal cancer. Molecular Therapy, 23:1532-1540.
    37.
  37. Rahman, M.M. & McFadden, G. (2020). Oncolytic Virotherapy with Myxoma Virus. Journal of Clinical Medicine, 9:171.
    38.
  38. Salvesen GS, Dixit VM. (1997). Caspases: intracellular signaling by proteolysis. Cell, 91:443–6.
    39.
  39. Southam, C. M. & Moore, A. E. (1952). Clinical studies of viruses as antineoplastic agents, with particular reference to Egypt 101 virus. Cancer, 5:1025-1034.
    40.
  40. Strong, J. E., Coffey, M. C., Tang, D., Sabinin, P. & Lee, P. W. (1998). The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. The EMBO journal, 17:3351-3362. ‏‏
    41.
  41. Suarez, D.L., Miller, P.J., Koch, G., Mundt, E. & Rautenschlein, S. (2020). Newcastle disease, other avian paramyxoviruses, and avian metapneumovirus infections. Diseases of poultry, 109-166.
    42.
  42. Thompson, CB. (1995). Apoptosis in the pathogenesis and treatment of disease. Science, 267:1456-1462.
    43.
  43. Thornberry, N.A. & Lazebnik, Y. (1998). Caspases: enemies within. Science, 281:1312–6.
    44.
  44. Vigil, A., Martinez, O., Chua, M. A. & García-Sastre, A. (2008). Recombinant Newcastle disease virus as a vaccine vector for cancer therapy. Molecular Therapy, 16:1883-1890.
    45.
  45. Vijayakumar, G. & Zamarin, D. (2020). Design and production of newcastle disease virus for intratumoral immunomodulation. In Oncolytic Viruses(133-154). Humana, New York, NY.
    46.
  46. Watkins, S. J., Mesyanzhinov, V. V., Kurochkina, L. P. & Hawkins, R. E. (1997). The ‘adenobody’approach to viral targeting: specific and enhanced adenoviral gene delivery. Gene therapy, 4:1004-1012.
    47.
  47. Woo, Y., Reid, V., Kelly, K.J., Carlson, D., Yu, Z. & Fong, Y. (2020). Oncolytic Herpes Simplex Virus Prevents Premalignant Lesions from Progressing to Cancer. Molecular Therapy-Oncolytics, 16:1-6.
    48.
  48. Yaghchi, C. A., Zhang, Z., Alusi, G., Lemoine, N. R. & Wang, Y. (2015). Vaccinia virus, a promising new therapeutic agent for pancreatic cancer. Immunotherapy, 7:1249-1258.
    49.
  49. Yuan, J. S., Reed, A., Chen, F. & Stewart, C. N. (2006). Statistical analysis of real-time PCR data. BMC bioinformatics, 7:
    50.
  50. Zamarin, D., Holmgaard, R. B., Ricca, J., Plitt, T., Palese, P., Sharma, P., ... & Allison, J. P. (2017). Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity. Nature communications, 8:1-14.
    51.
  51. Zamarin, D., Vigil, A., Kelly, K., García-Sastre, A. & Fong, Y. (2009). Genetically engineered Newcastle disease virus for malignant melanoma therapy. Gene therapy, 16:796-804. ‏ ‏‏
    52.
  52. Zhao, H., Janke, M., Fournier, P. & Schirrmacher, V. (2008). Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy. Virus research, 136:75-80. ‏‏
    53.

 

Related articles

  • Print Date : 2019-09-21

  • Print Date : 2021-03-18

  • Print Date : 2020-08-22

  • Print Date : 2020-08-22

  • Print Date : 2020-03-19

  • Print Date : 2020-02-20

The rights to this website are owned by the Raimag Press Management System.
Copyright © 2021-2024

Home| Login| About Us| Contact Us|
[فارسی] [العربية] [fa] [ar]